BioArctic AB's (publ) partner Eisai today announced that the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) in Mexico has approved Leqembi (lecanemab) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback